Skip to main navigation Skip to search Skip to main content

Mechanistic PK/PD Analysis of CCR1 Antagonist

Project: Research

Project Details

StatusFinished
Effective start/end date10/1/12 → 05/6/13

Funding

  • Bristol Myers Squibb Company: $41,974.53